Emergent BioSolutions Inc. (EBS) Form 10-K Annual Reports
Emergent BioSolutions Inc. (EBS) is a publicly traded company on the NYSE, categorized under SIC 2834 (Pharmaceutical Preparations). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: EBS
CIK: 1367644
Exchange: NYSE
SIC 2834: Pharmaceutical Preparations
Fiscal Year End: 12/31
State: DE
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
Ernst & Young LLP
Auditor SinceSince 12/31/2016 12:00:00 AM
Lead Engagement PartnerBrett Rembold
Audit LocationTysons, Virginia, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| 8-K | 2026-10-16 | 2026-10-16 | 8-K CFO 10.16.2026 | 0001367644-26-000098 | View SEC Doc Filr Page |
| 144 | 2026-10-07 | — | 144 Filing | 0001950047-26-010097 | View SEC Doc Filr Page |
| 4 | 2026-10-07 | 2026-10-07 | FORM 4 | 0001583098-26-000008 | View SEC Doc Filr Page |
| 4 | 2026-10-05 | 2026-10-01 | FORM 4 | 0001961994-26-000029 | View SEC Doc Filr Page |
| 144 | 2026-10-01 | — | 144 Filing | 0001950047-26-009931 | View SEC Doc Filr Page |
| 8-K | 2026-09-14 | 2026-09-14 | 8-K | 0001367644-26-000091 | View SEC Doc Filr Page |
| 8-K | 2026-09-01 | 2026-08-18 | 8-K | 0001367644-26-000088 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-08-14 | — | SCHEDULE 13G Filing | 0000052388-26-000262 | View SEC Doc Filr Page |
| 3 | 2026-08-12 | 2026-08-05 | FORM 3 | 0002149575-26-000007 | View SEC Doc Filr Page |
| 10-Q | 2026-08-06 | 2026-06-30 | 10-Q | 0001367644-26-000082 | View SEC Doc Filr Page |
| 8-K | 2026-08-05 | 2026-08-05 | 8-K | 0001367644-26-000080 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-07-31 | — | SCHEDULE 13G/A Filing | 0002100119-26-001413 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-07-28 | — | SCHEDULE 13G/A Filing | 0002012383-26-002482 | View SEC Doc Filr Page |
| 4 | 2026-07-02 | 2026-07-01 | FORM 4 | 0001961994-26-000024 | View SEC Doc Filr Page |
| 144 | 2026-07-01 | — | 144 Filing | 0001950047-26-006683 | View SEC Doc Filr Page |
| 8-K | 2026-06-29 | 2026-06-26 | 8-K | 0001367644-26-000068 | View SEC Doc Filr Page |
| 4 | 2026-06-10 | 2026-06-08 | FORM 4 | 0001961994-26-000021 | View SEC Doc Filr Page |
| 4 | 2026-06-10 | 2026-06-08 | FORM 4 | 0001196632-26-000017 | View SEC Doc Filr Page |
| 4 | 2026-06-10 | 2026-06-08 | FORM 4 | 0001919170-26-000016 | View SEC Doc Filr Page |
| 4 | 2026-06-10 | 2026-06-08 | FORM 4 | 0001989644-26-000011 | View SEC Doc Filr Page |
| 4 | 2026-05-04 | 2026-04-30 | FORM 4 | 0001536908-26-000004 | View SEC Doc Filr Page |
| 4 | 2026-05-04 | 2026-04-30 | FORM 4 | 0001583098-26-000004 | View SEC Doc Filr Page |
| 4 | 2026-05-04 | 2026-04-30 | FORM 4 | 0001314596-26-000002 | View SEC Doc Filr Page |
| 4 | 2026-05-04 | 2026-04-30 | FORM 4 | 0001493324-26-000002 | View SEC Doc Filr Page |
| 4 | 2026-05-04 | 2026-04-30 | FORM 4 | 0001190344-26-000012 | View SEC Doc Filr Page |